IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAH1. A total of 19 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,281,500 | -4.2% | 9,500,000 | 0.0% | 0.05% | 0.0% |
| Q2 2023 | $9,684,775 | +2.0% | 9,500,000 | 0.0% | 0.05% | +4.3% |
| Q1 2023 | $9,495,440 | -9.0% | 9,500,000 | 0.0% | 0.05% | -6.1% |
| Q4 2022 | $10,437,460 | +7.4% | 9,500,000 | 0.0% | 0.05% | +11.4% |
| Q3 2022 | $9,722,000 | -4.8% | 9,500,000 | 0.0% | 0.04% | 0.0% |
| Q2 2022 | $10,215,000 | -9.4% | 9,500,000 | 0.0% | 0.04% | +4.8% |
| Q1 2022 | $11,276,000 | +4.0% | 9,500,000 | 0.0% | 0.04% | +2.4% |
| Q4 2021 | $10,840,000 | -5.6% | 9,500,000 | 0.0% | 0.04% | -18.0% |
| Q3 2021 | $11,484,000 | +0.8% | 9,500,000 | 0.0% | 0.05% | -3.8% |
| Q2 2021 | $11,397,000 | +6.0% | 9,500,000 | 0.0% | 0.05% | -11.9% |
| Q1 2021 | $10,748,000 | +0.6% | 9,500,000 | 0.0% | 0.06% | -4.8% |
| Q4 2020 | $10,688,000 | +13.7% | 9,500,000 | 0.0% | 0.06% | +1.6% |
| Q3 2020 | $9,404,000 | – | 9,500,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAMDEN ASSET MANAGEMENT L P /CA | 35,225,000 | $39,760,000 | 1.94% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,079,000 | $4,662,000 | 0.54% |
| AQR Arbitrage LLC | 11,500,000 | $13,038,000 | 0.47% |
| Context Capital Management, LLC | 3,934 | $4,460,000 | 0.44% |
| Polar Asset Management Partners Inc. | 7,000,000 | $7,938,000 | 0.08% |
| Calamos Advisors LLC | 9,500,000 | $10,748,000 | 0.06% |
| LINDEN ADVISORS LP | 6,201,000 | $7,007,000 | 0.05% |
| LAZARD ASSET MANAGEMENT LLC | 14,500,000 | $16,439,000 | 0.02% |
| Citadel Advisors | 68,788,000 | $77,681,000 | 0.02% |
| PUTNAM INVESTMENTS LLC | 7,976,000 | $9,002,000 | 0.02% |